MDMA has been approved for use in a clinical trial for terminally ill patients
The Drug Enforcement Administration has approved the use of MDMA in a clinical trial to treat anxiety associated with terminal illness. A clinical trial run by the Multidisciplinary Association for Psychedelic Studies (MAPS) will give 18 participants various doses of MDMA to test their reactions, Engadget reports.
Despite its EDM festival reputation, MDMA is thought to be a useful anxiety treatment because of its ability to induce euphoria and empathy in users. Brad Burge, director of communications at MAPS, says the trial is most interested in studying how MDMA relates to arousal.
This isn’t your EDM festival MDMA
“When that arousal comes about in an unsafe situation, such as outside of therapy, or in a recreational context it may…
Source:: The Verge